It has been a long-drawn battle for the life sciences industry. Data and application sprawl, disparate systems, legacy infrastructure, and data security and regulatory compliance concerns, as well as data interoperability challenges resulting from varying data standards between electronic health records (EHRs) and electronic data capture (EDC) systems, have stalled innovation and escalated costs over the years. In addition, mergers and acquisitions (M&As) and restructuring initiatives have only added to the complexity.